Clinical Trial Update: Optimizing Reperfusion to Improve Outcomes and Neurologic Function [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial by Corxel Pharmaceuticals on optimizing reperfusion to improve outcomes and neurologic function in acute ischemic stroke is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Corxel Pharmaceuticals | Conditions: Acute Ischemic Stroke | Phase 2, Phase 3 | Status: RECRUITING